AI steps up in healthcare: GPT-3.5 and 4 excel in clinical reasoning

Study explores the use of large language models (LLMs) like GPT-3.5 and GPT-4 in simulating diagnostic clinical reasoning, using diagnostic reasoning prompts to assess their capabilities.

Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company’s inaugural globalization venture – Biotech Investments

New York, 11/16/2023 / 08:01, EST/EDT – EQS Newswire – Laxxon Medical NEW YORK, NY / ACCESSWIRE / November 16, 2023 / Pharmaceutical 3D screen

November 17, 2023

Study links lifestyle choices and gender to severity of fatty liver disease in workers

Study investigates the correlation between lifestyle factors, gender, inflammation, liver dysfunction, and metabolic abnormalities with fatty liver disease severity, revealing that men are at higher

November 15, 2023

Rosemont expands liquid medicine portfolio with Lucis acquisition – Pharmaceutical Technology

The company will develop Lucis’ liquid pipeline products. Source: Shutterstock / Matveev Aleksandr. Oral liquid medicine manufacturer Rosemont Pharmaceuticals has announced the acquisition of Lucis

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.